Monte Rosa Therapeutics, Inc. — SC 13G/A Filings
16 SC 13G/A filings on record
This page lists all SC 13G/A filings submitted to the SEC by Monte Rosa Therapeutics, Inc. (GLUE), sorted by most recent first. Each row links to the full filing on EdgarLookup. Monte Rosa Therapeutics, Inc. has filed 16 SC 13G/A documents with the SEC since 2020. To view all SEC filings by Monte Rosa Therapeutics, Inc., see the full filings list.
All
10-K
10-Q
144
144/A
3
4
424B4
424B5
8-A12B
8-K
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
PRE 14A
S-1
S-1/A
S-1MEF
S-3
S-3ASR
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SC 13G/A | — | 0000080255-24-001467 | Nov 14, 2024 | — |
| SC 13G/A | — | 0000315066-24-002827 | Nov 12, 2024 | — |
| SC 13G/A | — | 0000080255-24-000836 | Apr 10, 2024 | — |
| SC 13G/A | AMENDMENT NO. 3 | 0000929638-24-000644 | Feb 14, 2024 | — |
| SC 13G/A | — | 0001086364-24-007037 | Feb 14, 2024 | — |
| SC 13G/A | — | 0000080255-24-000762 | Feb 14, 2024 | — |
| SC 13G/A | MONTE ROSA THERAPEUTICS, INC. | 0000902664-24-001601 | Feb 14, 2024 | — |
| SC 13G/A | — | 0000315066-24-001315 | Feb 9, 2024 | — |
| SC 13G/A | — | 0000929638-23-000565 | Feb 14, 2023 | — |
| SC 13G/A | — | 0000080255-23-002733 | Feb 14, 2023 | — |
| SC 13G/A | MONTE ROSA THERAPEUTICS, INC. | 0000902664-23-001689 | Feb 14, 2023 | — |
| SC 13G/A | — | 0000315066-23-001955 | Feb 9, 2023 | — |
| SC 13G/A | — | 0000929638-22-000481 | Feb 14, 2022 | — |
| SC 13G/A | — | 0000080255-22-000973 | Feb 10, 2022 | — |
| SC 13G/A | — | 0000834237-22-008617 | Feb 9, 2022 | — |
| SC 13G/A | — | 0000315066-22-001069 | Feb 9, 2022 | — |